Renovaro Biosciences
RENB
#8801
Rank
ยฃ76.71 M
Marketcap
ยฃ0.47
Share price
-4.43%
Change (1 day)
-81.39%
Change (1 year)

Earnings for Renovaro Biosciences (RENB)

Earnings in 2024 (TTM): -ยฃ91.1 Million

According to Renovaro Biosciences's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -ยฃ32.5 Million, an increase over its 2022 earnings that were of -ยฃ85.58 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Renovaro Biosciences from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ91.1 Million180.37%
2023 -ยฃ32.5 Million-62.03%
2022 -ยฃ85.58 Million182.88%
2021 -ยฃ30.26 Million246.9%
2020 -ยฃ8.73 Million614.13%
2019 -ยฃ1.23 Million-93.65%
2018 -ยฃ19.24 Million1119.78%
2017 -ยฃ1.58 Million-29.21%
2016 -ยฃ2.23 Million
2014 -ยฃ2.02 Million6701.79%
2013 -ยฃ0.03 Million16.61%
2012 -ยฃ0.03 Million